A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity
Müller, Lutz, Mauthe, Robert J., Riley, Christopher M., Andino, Marta M., Antonis, David De, Beels, Chris, DeGeorge, Joseph, De Knaep, Alfons G.M., Ellison, Dean, Fagerland, Jane A., Frank, Rebecca, Fritschel, Betsy, Galloway, Sheila, Harpur, Ernie, Humfrey, Charles D.N., Jacks, Alexander S., Jagota, Nirdosh, Mackinnon, John, Mohan, Ganapathy, Ness, Daniel K., O’Donovan, Michael R., Smith, Mark D., Vudathala, Gopi, Yotti, Larry
Published in Regulatory toxicology and pharmacology (01.04.2006)
Published in Regulatory toxicology and pharmacology (01.04.2006)
Get full text
Journal Article